| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veracyte, Inc. (VCYT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. VCYT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 318.6K | $12.88M | - | |
| CFO | 109.5K | $4.43M | - | |
| Other | 89.5K | $3.62M | - | |
| Other | 82.1K | $3.32M | - | |
| VP | 67.8K | $2.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Bhanji Muna62 | Director | Sell | 3,870 | $20.32 | $78,633.76 | -14.3% | +39.3% | +33.5% | |
| Jun 7, 2024 | Eastham Karin67 | Director | Sale+OE | 2,500 | $20.97 | $52,425.00 | -7.0% | +44.2% | +33.0% | |
| May 28, 2024 | Bhanji Muna62 | Director | Sell | 1,539 | $21.00 | $32,319.00 | -5.4% | +50.7% | +24.6% | |
| Apr 1, 2024 | Eastham Karin67 | Director | Sale+OE | 10,000 | $21.65 | $216,528.00 | -23.2% | -1.4% | +36.6% | |
| Mar 1, 2024 | Jones Evan/ Fa70 | Director | Sale+OE | 10,000 | $24.36 | $243,599.00 | -21.0% | -12.5% | +44.8% | |
| Jul 19, 2023 | Jones Evan/ Fa70 | Director | Sell | 3,928 | $30.17 | $118,489.56 | -5.1% | -26.5% | -18.3% | |
| Jul 18, 2023 | Jones Evan/ Fa70 | Director | Sell | 52,809 | $30.09 | $1,588,918.17 | -24.5% | -28.5% | -15.1% | |
| Jul 18, 2023 | Bishop John L | Director | Sale+OE | 20,000 | $30.25 | $605,002.00 | -23.2% | -28.5% | -15.1% | |
| Jun 16, 2023 | Bhanji Muna62 | Director | Sell | 5,893 | $26.44 | $155,785.55 | -9.4% | -3.4% | -19.6% | |
| May 30, 2023 | Bhanji Muna62 | Director | Sell | 1,539 | $25.91 | $39,875.49 | -5.9% | -2.5% | -19.0% |